Literature DB >> 32986835

Response to Zahl.

Solveig Hofvind1,2, Sofie Sebuødegård1, Edoardo Botteri3,4.   

Abstract

Year:  2020        PMID: 32986835      PMCID: PMC7669222          DOI: 10.1093/jnci/djaa130

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  Effect of screening and adjuvant therapy on mortality from breast cancer.

Authors:  Donald A Berry; Kathleen A Cronin; Sylvia K Plevritis; Dennis G Fryback; Lauren Clarke; Marvin Zelen; Jeanne S Mandelblatt; Andrei Y Yakovlev; J Dik F Habbema; Eric J Feuer
Journal:  N Engl J Med       Date:  2005-10-27       Impact factor: 91.245

2.  Breast Cancer Mortality After Implementation of Organized Population-Based Breast Cancer Screening in Norway.

Authors:  Sofie Sebuødegård; Edoardo Botteri; Solveig Hofvind
Journal:  J Natl Cancer Inst       Date:  2020-08-01       Impact factor: 13.506

3.  Mode of detection: an independent prognostic factor for women with breast cancer.

Authors:  Solveig Hofvind; Åsne Holen; Marta Román; Sofie Sebuødegård; Montse Puig-Vives; Lars Akslen
Journal:  J Med Screen       Date:  2015-11-17       Impact factor: 2.136

4.  Stage-specific survival has improved for young breast cancer patients since 2000: but not equally.

Authors:  Cassia Bree Trewin; Anna Louise Viktoria Johansson; Kirsti Vik Hjerkind; Bjørn Heine Strand; Cecilie Essholt Kiserud; Giske Ursin
Journal:  Breast Cancer Res Treat       Date:  2020-06-03       Impact factor: 4.872

5.  Limitations in the Effect of Screening on Breast Cancer Mortality.

Authors:  Anna-Belle Beau; Per Kragh Andersen; Ilse Vejborg; Elsebeth Lynge
Journal:  J Clin Oncol       Date:  2018-09-04       Impact factor: 44.544

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.